Adjuvant docetaxel plus doxorubicin and cyclophosphamide increases survival compared with fluorouracil plus doxorubicin and cyclophosphamide in women with operable node-positive breast cancer.
Roy
Vivek
V
Mayo Clinic Jacksonville, Jacksonville, FL, USA.
Perez
Edith A
EA